Unfolding Genetic Origami in the Tonsils: A 3D Genome Atlas Traces Antibody Maturation

Antibodies are not produced solely according to a fixed genetic blueprint. After encountering an antigen, B cells also rewrite antibody genes within the germinal centers of lymphoid tissues such as the tonsils, selecting versions with better binding affinity from among numerous variants. A Yale University team has now examined this maturation process within an intact tissue environment, depicting how chromosomes inside the cell nucleus are rearranged during an immune response.

Published in *Science*, the study combined sequencing-based and imaging-based 3D genomics with transcriptomic analysis to create a single-cell 3D genome atlas of the human tonsil. The research team said it is the first 3D genome atlas of a human organ produced using imaging methods. It not only identifies cell types but also tracks how chromatin compartments, loop contacts, and their positions within the cell nucleus change as B cells transition between states.

The key tool was multiplexed imaging of nucleome architectures, or MINA. In ultrathin tonsil sections, the researchers used fluorescent signals to simultaneously locate DNA, RNA, and proteins, thereby preserving the relationships between cells and neighboring tissues. They then performed cross-analysis using Droplet Hi-C, chromatin tracing, and other molecular methods. Compared with sequencing after cells have been dissociated, this approach can reveal whether genome folding differs when the same type of cell is situated in different microenvironments.

The team focused particularly on “somatic hypermutation”: B cells deliberately accumulate mutations in immunoglobulin genes, thereby improving antibodies’ ability to recognize antigens. The atlas showed that gene regions more prone to hypermutation had more internal chromatin loops, while regions less prone to mutation had fewer. This established a more concrete link between the genome’s three-dimensional shape and antibody diversification.

To test whether the two merely occurred together, the researchers targeted RAD21, a component of the cohesin complex, for degradation in a B-cell lymphoma cell line. Somatic hypermutation subsequently stopped, indicating that the molecular machinery responsible for chromatin loop extrusion plays a necessary role. However, some chromatin loops previously considered important disappeared more slowly, suggesting that RAD21’s effects cannot be explained solely by “the loops being dismantled.” The steps that actually connect genome structure with the mutational response remain unclear.

The atlas may also help researchers study how hypermutation contributes to B-cell lymphoma when it strays from antibody genes and mistakenly damages other genes. The team has made publicly available Droplet Hi-C, MINA, 3C-HTGTS, CUT&RUN, ChIP-seq, time-resolved transcriptional data, and analysis code to facilitate subsequent validation. However, the current mechanistic interventions were derived mainly from cell lines, and the study has not demonstrated that manipulating chromatin loops can safely improve vaccine responses or treat disease. Its findings are first and foremost a research map, rather than a medical approach ready for direct translation.